Epic Research Update : GSK Pharma Q3

Net Profit At Rs 128.7 Crore Versus Rs 101 Crore (YoY)

Net Sales At Rs 739 Crore Versus Rs 620.5 Crore (YoY)
EBITDA At Rs 157 Crore Versus Rs 108 Crore (YoY)
EBITDA Margin At 21.3 percent Versus 17.4 percent (YoY)
GSK Pharma appoints Andrew Aristidou as CFO & ED
Real Time News & Trading Trends Keep Liking Epic Research Private Limited

Facebook – Twitter – YouTube – Pinterest –Linkedin - Google+

For more information ✆ – 0731-6642300 or Visit http://www.epicresearch.co